LCII vs MRNA · P/E 16, rev $2.06B vs rev $145.0M
LCI Industries (LCII) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
LCI Industries (LCII) is a recreational vehicles company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported LCII revenue for 2026-06-30 was $2.06B. Net income was $130.1M. Revenue was up 88.8% from 2026-03-31 to 2026-06-30. LCII currently screens at market cap $2.52B and trailing P/E 16.3.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
LCII currently screens at market cap $2.52B and trailing P/E 16.3. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the LCII and MRNA stock pages for the full models.
Not investment advice.